Need help choosing the right code?
Ask CasePilot about procedures, modifiers, bundling, and coding guidance.
Try CasePilot© Copyright 2026 American Medical Association. All rights reserved.
Molecular diagnostics involve a series of tests designed to detect genetic mutations that may indicate the presence of certain diseases, even in patients who do not exhibit any symptoms. These tests play a crucial role in monitoring existing disease states, diagnosing conditions, and screening individuals who may be genetic carriers of diseases or predisposed to specific health issues that could benefit from preventive medical interventions. The process of molecular diagnostics often requires the preparation of nucleic acids, which can include undigested nucleic acids, digestates, or specially modified samples such as newly synthesized oligonucleotides. The primary focus of CPT® Code 83891 is the isolation or extraction of highly purified nucleic acids, specifically DNA or RNA. This purification process employs various techniques tailored to the type of study being conducted, including methods such as precipitation, chromatography, and centrifugation. It is important to note that the code is applicable for each nucleic acid type being tested, whether it is DNA or RNA, ensuring that the isolation or extraction is accurately reported for both types of nucleic acids involved in the diagnostic process.
© Copyright 2026 Coding Ahead. All rights reserved.
Molecular diagnostics using CPT® Code 83891 are indicated for a variety of clinical scenarios, including but not limited to the following:
The procedure for CPT® Code 83891 involves several key steps to ensure the successful isolation or extraction of highly purified nucleic acids. Each step is critical to the integrity and quality of the nucleic acid being prepared for analysis.
Post-procedure care for CPT® Code 83891 primarily involves the handling and storage of the isolated nucleic acids. It is essential to store the purified nucleic acids under appropriate conditions to maintain their stability and integrity for future analysis. Additionally, documentation of the extraction process, including any quality control results, is crucial for compliance and traceability. The results obtained from the molecular diagnostic tests can then be utilized for further clinical decision-making, including treatment planning and patient management.
| Short Descr | MOLECULE ISOLATE NUCLEIC | Medium Descr | MOLEC ISOL/XTRJ HP NUCLEIC ACID EA TYPE | Long Descr | Molecular diagnostics; isolation or extraction of highly purified nucleic acid, each nucleic acid type (ie, DNA or RNA) | Status Code | Statutory Exclusion (from MPFS, may be paid under other methodologies) | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | APC Status Indicator | Discontinued Code | Type of Service (TOS) | 5 - Diagnostic Laboratory | Berenson-Eggers TOS (BETOS) | none | MUE | Not applicable/unspecified. | CCS Clinical Classification | 233 - Laboratory - Chemistry and Hematology |
Get instant expert-level medical coding assistance.